Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Braun

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
European Urology Open Science|March 18, 2024
Integrative Analysis of Germline Rare Variants in Clear and Non-clear Cell Renal Cell CarcinomaSeung Hun Han, Sabrina Y Camp, Hoyin Chu, et al.
American Journal of Perinatology|June 23, 2022
Association between SARS-CoV-2 Infection and Adverse Perinatal Outcomes in a Large Health Maintenance OrganizationDarios Getahun, Morgan R Peltier, Lawrence D Lurvey, et al.
The Journal of Pediatrics|June 23, 2023
Discontinuation of Car Seat Tolerance Screening and Postdischarge Adverse Outcomes in Infants Born PretermDavid Braun, Joseph W Kaempf, Ngoc J Ho, et al.
Annals of the New York Academy of Sciences|June 1, 2016
The emerging threat of superwarfarins: history, detection, mechanisms, and countermeasuresDouglas L Feinstein, Belinda S Akpa, Manuela A Ayee, et al.
Hospital Pediatrics|May 1, 2019
Using NHSN's Antimicrobial Use Option to Monitor and Improve Antibiotic Stewardship in NeonatesErin N O'Leary, Katharina L van Santen, Erika M Edwards, et al.
Journal for Immunotherapy of Cancer|March 22, 2023
Phase II study of nivolumab and salvage nivolumab/ipilimumab in treatment-naïve patients with advanced non-clear cell renal cell carcinoma (HCRN GU16-260-Cohort B)Michael B Atkins, Opeyemi A Jegede, Naomi B Haas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2022
Phase II Study of Nivolumab and Salvage Nivolumab/Ipilimumab in Treatment-Naive Patients With Advanced Clear Cell Renal Cell Carcinoma (HCRN GU16-260-Cohort A)Michael B Atkins, Opeyemi A Jegede, Naomi B Haas, et al.
Journal of Behavioral Addictions|May 4, 2023
On the current psychotherapeutic situation for persons with pornography use disorder in GermanyCharlotte Markert, Florian Storz, Sarah Golder, et al.
Nature Communications|September 27, 2019
Metabolomic adaptations and correlates of survival to immune checkpoint blockadeHaoxin Li, Kevin Bullock, Carino Gurjao, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Scaling Large Language Models for Next-Generation Single-Cell AnalysisSyed Asad Rizvi, Daniel Levine, Aakash Patel, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
European Urology Open Science|March 18, 2024
Integrative Analysis of Germline Rare Variants in Clear and Non-clear Cell Renal Cell CarcinomaSeung Hun Han, Sabrina Y Camp, Hoyin Chu, et al.
American Journal of Perinatology|June 23, 2022
Association between SARS-CoV-2 Infection and Adverse Perinatal Outcomes in a Large Health Maintenance OrganizationDarios Getahun, Morgan R Peltier, Lawrence D Lurvey, et al.
The Journal of Pediatrics|June 23, 2023
Discontinuation of Car Seat Tolerance Screening and Postdischarge Adverse Outcomes in Infants Born PretermDavid Braun, Joseph W Kaempf, Ngoc J Ho, et al.
Annals of the New York Academy of Sciences|June 1, 2016
The emerging threat of superwarfarins: history, detection, mechanisms, and countermeasuresDouglas L Feinstein, Belinda S Akpa, Manuela A Ayee, et al.
Hospital Pediatrics|May 1, 2019
Using NHSN's Antimicrobial Use Option to Monitor and Improve Antibiotic Stewardship in NeonatesErin N O'Leary, Katharina L van Santen, Erika M Edwards, et al.
Journal for Immunotherapy of Cancer|March 22, 2023
Phase II study of nivolumab and salvage nivolumab/ipilimumab in treatment-naïve patients with advanced non-clear cell renal cell carcinoma (HCRN GU16-260-Cohort B)Michael B Atkins, Opeyemi A Jegede, Naomi B Haas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2022
Phase II Study of Nivolumab and Salvage Nivolumab/Ipilimumab in Treatment-Naive Patients With Advanced Clear Cell Renal Cell Carcinoma (HCRN GU16-260-Cohort A)Michael B Atkins, Opeyemi A Jegede, Naomi B Haas, et al.
Journal of Behavioral Addictions|May 4, 2023
On the current psychotherapeutic situation for persons with pornography use disorder in GermanyCharlotte Markert, Florian Storz, Sarah Golder, et al.
Nature Communications|September 27, 2019
Metabolomic adaptations and correlates of survival to immune checkpoint blockadeHaoxin Li, Kevin Bullock, Carino Gurjao, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Scaling Large Language Models for Next-Generation Single-Cell AnalysisSyed Asad Rizvi, Daniel Levine, Aakash Patel, et al.
Pageof 7